• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国单一患者中出现两株产 NDM-1 的鸟氨酸罗伊氏菌和阴沟肠杆菌:可能是通过接合体内新型抗菌药物耐药质粒的转移。

Occurrence of two NDM-1-producing Raoultella ornithinolytica and Enterobacter cloacae in a single patient in China: probable a novel antimicrobial resistance plasmid transfer in vivo by conjugation.

机构信息

Department of Microbiology, School of Basic Medical Sciences, Hubei University of Medicine, Hubei, Shiyan 442000, China; Department of Clinical Laboratory, Affiliated dongfeng Hospital, Hubei University of Medicine, Hubei, Shiyan 442000, China; Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei, Shiyan 442000, China.

Department of Microbiology, School of Basic Medical Sciences, Hubei University of Medicine, Hubei, Shiyan 442000, China.

出版信息

J Glob Antimicrob Resist. 2020 Sep;22:835-841. doi: 10.1016/j.jgar.2020.06.022. Epub 2020 Jul 8.

DOI:10.1016/j.jgar.2020.06.022
PMID:32652247
Abstract

OBJECTIVES

To identify the general features of acquisition of drug-resistance genes in two multi-drug resistant Enterobacteriaceae strains isolated from a single patient in China.

METHODS

The whole-plasmid was sequenced by Illumina Hiseq 4000 and Pacbio RSII procedures. The plasmid conjugation transfer experiment were performed by the mating-out assay. Drug-resistance genes were amplified by PCR assay.

RESULTS

We identified two New Delhi metallo-β-lactamase type 1(NDM-1)-producing isolates, named Raoultella ornithinolytica B1645-1 and Enterobacter cloacae B1645-2, which shared the same sulfonamide-resistant dihydropteroate synthase sul2 gene and aminoglycoside O-phosphotransferase aph(3'')-Ib gene. A novel antimicrobial resistance plasmid pCYNDM01 was first discovered from the multi-drug resistant R. ornithinolytica B1645-1. Interestingly, plasmid pCYNDM01 carried a Gifsy-2 prophage gene. The bla gene was located on a novel complex class 1 integron with a structure of sul1-qacEΔ1-ΔISAba125-bla-bla-trpC-ISCR1-catb8-aacA4-IS1-IS6100-dfrA14-intI1. The carrying the bla gene plasmid pCYNDM01 was transferred to the E. cloacae B1645-2 recipient strain. This 149.44 kb plasmid pCYNDM01 belonged to the IncFII type.

CONCLUSIONS

A novel antimicrobial resistance plasmid pCYNDM01 was first recovered from a multi-drug resistance R. ornithinolytica B1645-1 isolated from China. The novel complex sul1-type class 1 integron might play an essential role in the mobilization of the bla gene among different enterobacterial species. The occurrence of plasmid pCYNDM01 transfer from R. ornithinolytica to E. cloacae in vitro by conjugation showed that plasmid pCYNDM01 was a self-conjugative plasmid and might cause dissemination of drug-resistance genes within different enterobacterial species from a single patient in vivo by conjugation. The novel variant F-like T4SS of plasmid pCYNDM01 might be as a tool of R. ornithinolytica B1645-1 for resistance genes transfer. The emergence of the two NDM-1-producing Enterobacteriaceae strains should be attracted China attentions and required to prevent its future prevalence.

摘要

目的

鉴定从中国的单一患者中分离出的两株多药耐药肠杆菌科菌株中耐药基因的获得的一般特征。

方法

采用 Illumina Hiseq 4000 和 Pacbio RSII 程序对全质粒进行测序。通过交配实验进行质粒接合转移实验。通过 PCR 实验扩增耐药基因。

结果

我们鉴定了两株新德里金属-β-内酰胺酶 1 型(NDM-1)产生的分离株,命名为鸟氨酸罗伊氏菌 B1645-1 和阴沟肠杆菌 B1645-2,它们共享相同的磺胺类耐药二氢喋呤合成酶 sul2 基因和氨基糖苷磷酸转移酶 aph(3')-Ib 基因。首次从多药耐药的 R. ornithinolytica B1645-1 中发现了一种新型的抗菌药物耐药质粒 pCYNDM01。有趣的是,质粒 pCYNDM01 携带了 Gifsy-2 噬菌体基因。bla 基因位于一个新型的复杂 1 类整合子上,其结构为 sul1-qacEΔ1-ΔISAba125-bla-bla-trpC-ISCR1-catb8-aacA4-IS1-IS6100-dfrA14-intI1。携带 bla 基因的质粒 pCYNDM01 被转移到阴沟肠杆菌 B1645-2 受体菌株中。这个 149.44kb 的质粒 pCYNDM01 属于 IncFII 型。

结论

首次从中国多药耐药的 R. ornithinolytica B1645-1 中回收了一种新型的抗菌药物耐药质粒 pCYNDM01。新型复杂的 sul1 型 1 类整合子可能在不同肠杆菌种之间 bla 基因的转移中起重要作用。通过接合,质粒 pCYNDM01 从鸟氨酸罗伊氏菌转移到阴沟肠杆菌的体外转移表明,质粒 pCYNDM01 是一种自我接合性质粒,可能通过接合在体内从单一患者的不同肠杆菌种中传播耐药基因。质粒 pCYNDM01 的新型 F 样 T4SS 可能是 R. ornithinolytica B1645-1 用于耐药基因转移的工具。两株产 NDM-1 的肠杆菌科菌株的出现应引起中国的关注,并需要防止其未来流行。

相似文献

1
Occurrence of two NDM-1-producing Raoultella ornithinolytica and Enterobacter cloacae in a single patient in China: probable a novel antimicrobial resistance plasmid transfer in vivo by conjugation.中国单一患者中出现两株产 NDM-1 的鸟氨酸罗伊氏菌和阴沟肠杆菌:可能是通过接合体内新型抗菌药物耐药质粒的转移。
J Glob Antimicrob Resist. 2020 Sep;22:835-841. doi: 10.1016/j.jgar.2020.06.022. Epub 2020 Jul 8.
2
NDM-producing Enterobacteriaceae in a Chinese hospital, 2014-2015: identification of NDM-producing Citrobacterwerkmanii and acquisition of blaNDM-1-carrying plasmid in vivo in a clinical Escherichia coli isolate.2014 - 2015年中国一家医院产新德里金属β-内酰胺酶(NDM)的肠杆菌科细菌:产NDM的克氏柠檬酸杆菌的鉴定以及临床分离大肠埃希菌体内携带blaNDM - 1质粒的获得
J Med Microbiol. 2016 Nov;65(11):1253-1259. doi: 10.1099/jmm.0.000357. Epub 2016 Sep 23.
3
Transmission and characterization of bla in Enterobacter cloacae at a teaching hospital in Yunnan, China.中国云南某教学医院阴沟肠杆菌中bla的传播与特征分析
Ann Clin Microbiol Antimicrob. 2017 Aug 22;16(1):58. doi: 10.1186/s12941-017-0232-y.
4
Characterization of an New Delhi-Metallo-1-Producing ST418 Strain from a Patient in Guangzhou, China.一株中国广州产新德里金属β-内酰胺酶 1 型(NDM-1)阳性 ST418 型大肠埃希菌的耐药特征
Microb Drug Resist. 2021 May;27(5):706-709. doi: 10.1089/mdr.2020.0035. Epub 2020 Oct 21.
5
New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China.新德里金属β-内酰胺酶1(NDM-1),在中国河南省耐碳青霉烯类阴沟肠杆菌中检测到的主要碳青霉烯酶。
PLoS One. 2015 Aug 11;10(8):e0135044. doi: 10.1371/journal.pone.0135044. eCollection 2015.
6
Outbreak of Efficiently Transferred Carbapenem-Resistant -Producing Gram-Negative Bacilli Isolated from Neonatal Intensive Care Unit of an Indian Hospital.产碳青霉烯酶的革兰氏阴性杆菌在印度医院新生儿重症监护病房的爆发式传播。
Microb Drug Resist. 2020 Mar;26(3):284-289. doi: 10.1089/mdr.2019.0092. Epub 2019 Aug 9.
7
Characterization of a blaNDM-1-carrying IncHI5 plasmid from Enterobacter cloacae complex of food-producing animal origin.产肠杆菌科食品源动物携带 blaNDM-1 的 IncHI5 型质粒的特性研究。
J Antimicrob Chemother. 2020 May 1;75(5):1140-1145. doi: 10.1093/jac/dkaa010.
8
Genomic analysis of two bacterial strains co-isolated from a urinary tract infection: NDM-1-producing Enterobacter cloacae accompanied by extended-spectrum β-lactamase-producing Escherichia coli.两种细菌从尿路感染中共分离的基因组分析:同时产 NDM-1 的阴沟肠杆菌和产超广谱β-内酰胺酶的大肠埃希菌。
J Glob Antimicrob Resist. 2019 Jun;17:198-200. doi: 10.1016/j.jgar.2019.04.007. Epub 2019 Apr 18.
9
Emergence of IncFIA Plasmid-Carrying Among and Isolates in a Tertiary Referral Hospital in Mexico.在墨西哥一家三级转诊医院中,IncFIA 质粒携带菌在 和 分离株中出现。
Microb Drug Resist. 2019 Jul/Aug;25(6):830-838. doi: 10.1089/mdr.2018.0306. Epub 2019 Mar 5.
10
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece.希腊高产 NDM-1 型碳青霉烯酶肠杆菌科细菌 ST182 克隆相关的阴沟肠杆菌复合体临床分离株。
Int J Antimicrob Agents. 2023 Jul;62(1):106837. doi: 10.1016/j.ijantimicag.2023.106837. Epub 2023 May 6.

引用本文的文献

1
Effects of Luteolin-7-O-Glucoside on Intestinal Microbiota Dysbiosis and Drug Resistance Transmission Caused by B1645-1: Modulating the Composition of Intestinal Microbiota and Promoting the Transfer of Gene from Genus to in Mice.木犀草素-7-O-葡萄糖苷对B1645-1引起的肠道微生物群失调和耐药性传播的影响:调节小鼠肠道微生物群组成并促进基因在属间转移
Microorganisms. 2023 Oct 2;11(10):2477. doi: 10.3390/microorganisms11102477.
2
Probable Three-Species In Vivo Transfer of in a Single Patient in Greece: Occurrence of NDM-1-Producing , , and .希腊一名患者体内可能发生的三种细菌的体内转移:产NDM-1的肺炎克雷伯菌、大肠埃希菌和奇异变形杆菌的出现
Antibiotics (Basel). 2023 Jul 20;12(7):1206. doi: 10.3390/antibiotics12071206.
3
Evolution of carbapenem resistance in klebsiella pneumoniae and escherichia coli carrying bla gene: imipenem exposure results in sustained resistance memory of strains in vitro.
产碳青霉烯酶肺炎克雷伯菌和大肠埃希菌 bla 基因的演变:亚胺培南暴露导致体外菌株持续耐药记忆。
Ann Clin Microbiol Antimicrob. 2023 Jun 12;22(1):46. doi: 10.1186/s12941-023-00598-8.